GL1X · GenesisL1 explorer

MolNFT v1 · #4819 · protein

Integrin ALPHA2 I domain / collagen complex

1DZI: “Integrin ALPHA2 I domain / collagen complex”. X-ray diffraction, 2 ligands (CO, NH2), 2 pockets (best druggability 0.47). MolNFT v1 #4819 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1DZI
Type
protein
Length
248 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Integrin; Collagen
UniProt
P17301
Ligands
CO, NH2
Pockets
2 · best druggability 0.47

Structure

x-ray diffraction · 2 distinct chains · 36% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AIntegrinprotein18540% helix, 21% strandP17301
B, C, DCollagenprotein210% helix, 0% strand—

Ligands and binding sites

  • CO · Cobalt (II) ion · metal · chains A, C
  • NH2 · Amino group · ion · 3 copies · chains B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11960.470.7529empty
2700.360.7614empty

Interfaces

6 interfaces between chains.

  • B–C · 698 Ų buried · 7 hydrogen bonds · protein-protein
  • C–D · 617 Ų buried · 6 hydrogen bonds · protein-protein
  • B–D · 601 Ų buried · 6 hydrogen bonds · protein-protein
  • A–C · 408 Ų buried · 13 hydrogen bonds · protein-protein
  • A–B · 298 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 18 modified (hydroxylation).

Compared structures

  • 1DZI · integrin alpha2 I domain / collagen complex · the same entry in another collection · chain A against A, TM-score 1.00
  • P17301 · AlphaFold monomer V2.0 prediction for integrin alpha-2 (P17301) · a predicted model of the same protein · chain A against A, TM-score 0.93

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.